Report Detail

Other Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Status and Forecast 2019-2025

  • RnM3640317
  • |
  • 02 August, 2019
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Other

Rapid influenza diagnostic tests (RIDTs) are immunoassays that can identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, and display the result in a qualitative way (positive vs. negative). In the United States, a number of RIDTs are commercially available. The reference standards for laboratory confirmation of influenza virus infection in respiratory specimens are reverse transcription-polymerase chain reaction (RT-PCR) or viral culture. RIDTs can yield results in a clinically relevant time frame, i.e., less than approximately 15 minutes. However, RIDTs have limited sensitivity to detect influenza viruses in respiratory specimens compared to RT-PCR or viral culture and negative RIDT test results should be interpreted with caution given the potential for false negative results, especially during peak influenza activity in a community. Some RIDTs use analyzer reader devices to standardize result interpretation.
The classification of Rapid Influenza Diagnostic Test (RIDT) includes Conventional RIDT and Digital RIDTs. The proportion of digital RIDTs in 2018 is about 53.35% of revenue.Rapid Influenza Diagnostic Test (RIDT) is application in hospital, POCT and others. The most of Rapid Influenza Diagnostic Test (RIDT) is used in hospital, and the market share of that is about 63.97% in 2018.North America is the largest consumption place, with a consumption market share nearly 53.65% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 26.27% in 2018.

Market competition is intense. BD, Abbot (Alere), Quidel, Roche, Thermo Fisher Scientific, Meridian Bioscience, Analytik Jena, Princeton BioMeditech Corporation, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, DiaSorin (Focus Diagnostics) are the leaders of the industry, and have been formed in the monopoly position in the industry.

In 2018, the global Rapid Influenza Diagnostic Test (RIDT) market size was 973.1 million US$ and it is expected to reach 1751.7 million US$ by the end of 2025, with a CAGR of 8.7% during 2019-2025.

This report focuses on the global Rapid Influenza Diagnostic Test (RIDT) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rapid Influenza Diagnostic Test (RIDT) development in North America and Europe..

The key players covered in this study
BD
Abbot (Alere)
Quidel
Roche
Thermo Fisher Scientific
Meridian Bioscience
Analytik Jena
Princeton BioMeditech Corporation
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
DiaSorin (Focus Diagnostics)

Market segment by Type, the product can be split into
Digital RIDTs
Conventional RIDT

In 2018, Digital RIDTs accounted for a major share of 55.36% the global Rapid Influenza Diagnostic Test (RIDT) market. And this product segment is poised to reach 1039.09 million US$ by 2025 from 588.84 million US$ in 2018.

Market segment by Application, split into
Hospitals
POCT
Others

In Rapid Influenza Diagnostic Test (RIDT) market, the Hospitals holds an important share in terms of application, and it is expected to reach revenue of by 2025, at a CAGR of 8.37% during 2019 and 2025.

Market segment by Regions/Countries, this report covers
North America
Europe

The study objectives of this report are:
To analyze global Rapid Influenza Diagnostic Test (RIDT) status, future forecast, growth opportunity, key market and key players.
To present the Rapid Influenza Diagnostic Test (RIDT) development in North America and Europe..
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rapid Influenza Diagnostic Test (RIDT) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Digital RIDTs
      • 1.4.3 Conventional RIDT
    • 1.5 Market by Application
      • 1.5.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 POCT
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Rapid Influenza Diagnostic Test (RIDT) Market Size
    • 2.2 Rapid Influenza Diagnostic Test (RIDT) Growth Trends by Regions
      • 2.2.1 Rapid Influenza Diagnostic Test (RIDT) Market Size by Regions (2019-2025)
      • 2.2.2 Rapid Influenza Diagnostic Test (RIDT) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Rapid Influenza Diagnostic Test (RIDT) Market Size by by Players
      • 3.1.1 Global Rapid Influenza Diagnostic Test (RIDT) Revenue by by Players (2014-2019)
      • 3.1.2 Global Rapid Influenza Diagnostic Test (RIDT) Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Rapid Influenza Diagnostic Test (RIDT) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rapid Influenza Diagnostic Test (RIDT) Key Players Head office and Area Served
    • 3.3 Key Players Rapid Influenza Diagnostic Test (RIDT) Product/Solution/Service
    • 3.4 Date of Enter into Rapid Influenza Diagnostic Test (RIDT) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Type (2014-2019)
    • 4.2 Global Rapid Influenza Diagnostic Test (RIDT) Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Rapid Influenza Diagnostic Test (RIDT) Market Size (2014-2019)
    • 5.2 Rapid Influenza Diagnostic Test (RIDT) Key Players in North America
    • 5.3 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Type
    • 5.4 North America Rapid Influenza Diagnostic Test (RIDT) Market Size by Application

    6 Europe

    • 6.1 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size (2014-2019)
    • 6.2 Rapid Influenza Diagnostic Test (RIDT) Key Players in Europe
    • 6.3 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Type
    • 6.4 Europe Rapid Influenza Diagnostic Test (RIDT) Market Size by Application

    7 International Players Profiles

    • 7.1 BD
      • 7.1.1 BD Company Details
      • 7.1.2 Company Description and Business Overview
      • 7.1.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.1.4 BD Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019))
      • 7.1.5 BD Recent Development
    • 7.2 Abbot (Alere)
      • 7.2.1 Abbot (Alere) Company Details
      • 7.2.2 Company Description and Business Overview
      • 7.2.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.2.4 Abbot (Alere) Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.2.5 Abbot (Alere) Recent Development
    • 7.3 Quidel
      • 7.3.1 Quidel Company Details
      • 7.3.2 Company Description and Business Overview
      • 7.3.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.3.4 Quidel Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.3.5 Quidel Recent Development
    • 7.4 Roche
      • 7.4.1 Roche Company Details
      • 7.4.2 Company Description and Business Overview
      • 7.4.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.4.4 Roche Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.4.5 Roche Recent Development
    • 7.5 Thermo Fisher Scientific
      • 7.5.1 Thermo Fisher Scientific Company Details
      • 7.5.2 Company Description and Business Overview
      • 7.5.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.5.4 Thermo Fisher Scientific Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.5.5 Thermo Fisher Scientific Recent Development
    • 7.6 Meridian Bioscience
      • 7.6.1 Meridian Bioscience Company Details
      • 7.6.2 Company Description and Business Overview
      • 7.6.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.6.4 Meridian Bioscience Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.6.5 Meridian Bioscience Recent Development
    • 7.7 Analytik Jena
      • 7.7.1 Analytik Jena Company Details
      • 7.7.2 Company Description and Business Overview
      • 7.7.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.7.4 Analytik Jena Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.7.5 Analytik Jena Recent Development
    • 7.8 Princeton BioMeditech Corporation
      • 7.8.1 Princeton BioMeditech Corporation Company Details
      • 7.8.2 Company Description and Business Overview
      • 7.8.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.8.4 Princeton BioMeditech Corporation Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.8.5 Princeton BioMeditech Corporation Recent Development
    • 7.9 BioMerieux
      • 7.9.1 BioMerieux Company Details
      • 7.9.2 Company Description and Business Overview
      • 7.9.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.9.4 BioMerieux Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.9.5 BioMerieux Recent Development
    • 7.10 Sekisui Diagnostics
      • 7.10.1 Sekisui Diagnostics Company Details
      • 7.10.2 Company Description and Business Overview
      • 7.10.3 Rapid Influenza Diagnostic Test (RIDT) Introduction
      • 7.10.4 Sekisui Diagnostics Revenue in Rapid Influenza Diagnostic Test (RIDT) Business (2014-2019)
      • 7.10.5 Sekisui Diagnostics Recent Development
    • 7.11 Response Biomedical
    • 7.12 SA Scientific
    • 7.13 DiaSorin (Focus Diagnostics)

    8 Market Forecast 2019-2025

    • 8.1 Market Size Forecast by Product (2019-2025)
    • 8.2 Market Size Forecast by Application (2019-2025)
    • 8.3 Market Size Forecast by Regions
    • 8.4 North America
    • 8.5 Europe

    9 Analyst's Viewpoints/Conclusions

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
          • 10.1.1.1 Research Programs/Design
          • 10.1.1.2 Market Size Estimation
          • 10.1.1.3 Market Breakdown and Data Triangulation
        • 10.1.2 Data Source
          • 10.1.2.1 Secondary Sources
          • 10.1.2.2 Primary Sources
      • 10.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Rapid Influenza Diagnostic Test (RIDT). Industry analysis & Market Report on Rapid Influenza Diagnostic Test (RIDT) is a syndicated market report, published as Global Rapid Influenza Diagnostic Test (RIDT) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Rapid Influenza Diagnostic Test (RIDT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,112.20
      4,668.30
      6,224.40
      3,638.70
      5,458.05
      7,277.40
      599,664.00
      899,496.00
      1,199,328.00
      325,494.00
      488,241.00
      650,988.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report